These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2239802)

  • 1. Oral carmofur in advanced gastrointestinal cancer.
    Gröhn P; Heinonen E; Kumpulainen E; Länsimies H; Lantto A; Salmi R; Pyrhönen S; Numminen S
    Am J Clin Oncol; 1990 Dec; 13(6):477-9. PubMed ID: 2239802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of oral carmofur in advanced pancreatic carcinoma.
    Kajanti MJ; Pyrhönen SO
    Ann Oncol; 1991; 2(10):765-6. PubMed ID: 1801884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancers.
    Ardalan B; Singh G; Silberman H
    J Clin Oncol; 1988 Jun; 6(6):1053-8. PubMed ID: 3373260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of polychemotherapy of cancer of the digestive organs].
    Singer Z; Kobylińska-Scieszkowa M; Dzieza-Lalowicz I; Starzewska H; Rogoń Z; Gejsler A
    Pol Tyg Lek; 1980 Sep; 35(38):1453-5. PubMed ID: 7465441
    [No Abstract]   [Full Text] [Related]  

  • 5. [Phase II study of carmofur (HCFU) fine granules].
    Koyama Y
    Gan To Kagaku Ryoho; 1982 May; 9(5):906-14. PubMed ID: 7184433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced gastrointestinal malignancy.
    Vaughn CB; Chapman JL; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Brady PR
    Oncology; 1981; 38(3):129-33. PubMed ID: 7010257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.
    Bullen BR; Giles GR; Malhotra A; Bird GG; Hall R; Bunch GA; Brown GJ
    Cancer Treat Rep; 1976 Sep; 60(9):1267-71. PubMed ID: 797448
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phase II study of 590-S (1-phthalidyl-5-fluorouracil) in patients with gastrointestinal cancer. Tokyo Cancer Chemotherapy Cooperative Group].
    Nakatsu T; Takahashi H; Furue H
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3114-8. PubMed ID: 3674897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant chemotherapy in cancers of the stomach, pancreas and intestine].
    Martin F
    Bull Cancer; 1984; 71(4):374-6. PubMed ID: 6498350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An individual patient data meta-analysis of long supported adjuvant chemotherapy with oral carmofur in patients with curatively resected colorectal cancer.
    Sakamoto J; Kodaira S; Hamada C; Ito K; Maehara Y; Takagi H; Sugimachi K; Nakazato H; Ohashi Y;
    Oncol Rep; 2001; 8(3):697-703. PubMed ID: 11295105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-day continuous infusion of 5-fluorouracil for advanced colorectal, gastric, and pancreatic adenocarcinoma.
    Hartman HA; Kessinger A; Lemon HM; Foley JF
    J Surg Oncol; 1979; 11(3):227-38. PubMed ID: 459516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of high-dose 5-fluorouracil with razoxane or adriamycin in the treatment of advanced adenocarcinoma of the gastrointestinal tract.
    Smith BJ; Ashford RF; Bakowski M; Hellman K; Newton K; Phillips R; Lambert J; Jones R; Peters N; Evans M
    Am J Clin Oncol; 1983 Aug; 6(4):481-4. PubMed ID: 6346856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy for gastrointestinal malignancy.
    Van der Veer LD; Balint JA
    Am J Gastroenterol; 1980 Jul; 74(1):40-9. PubMed ID: 7424879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal tumors: chemotherapeutic preparations].
    Queisser W; Heim ME
    Fortschr Med; 1983 Apr; 101(13):583-6. PubMed ID: 6852723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibilities and limitations of the cytostatic treatment of gastrointestinal carcinoma.
    Trux F
    Hepatogastroenterology; 1982 Jun; 29(3):130-3. PubMed ID: 7049880
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of oral ftorafur and intravenous 5-fluorouracil in patients with advanced cancer of the stomach, colon or rectum.
    Bjerkeset T; Fjøsne HE
    Oncology; 1986; 43(4):212-5. PubMed ID: 3088506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
    Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
    J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined 5-fluorouracil and hydroxyurea therapy for gastrointestinal cancer.
    Lokich JJ; Pitman SW; Skarin AT
    Oncology; 1975; 32(1):34-7. PubMed ID: 1208028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.